Colesevelam curbs glucose concentration in study

01/31/2013 | PhysiciansBriefing.com

Colesevelam therapy was associated with lower fasting and postprandial glucose concentrations in type 2 diabetes patients on metformin monotherapy, a study in Diabetes found. Researchers also discovered colesevelam did not affect insulin concentration, secretion or action in patients.

View Full Article in:

PhysiciansBriefing.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL